CANNAPHARMARX, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.9M | $-382.0K | $-1.5M | $-1.4M | $-690.6K | $-3.7M | $188.4K | $5.4M |
| Depreciation & Amortization | — | $15.8K | $0 | $0 | $0 | — | $0 | $64.2K |
| Depreciation | — | — | — | — | — | — | $0 | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | $0 | — |
| Net Cash from Operating Activities | $-127.4K | $-243.7K | $-802.7K | $-446.5K | $-601.4K | — | $-540.9K | $-427.6K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $242.5K | — | — | $600.4K | — | — | — |
| Net Change in Cash | — | $-1.2K | — | — | $-948 | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |